Assign modules on offcanvas module position to make them visible in the sidebar.

In combination with traditional treatment of type 1 diabetes, stem cells (FSC) can help:

• end the auto-aggression of cell-mediated immunity factors against β-cells;

• prevent the destruction of β-cells that are functional at the time of the treatment;

• restore the patient’s own β-cells and improve their functional capacity;

• prevent diabetes-related complications affecting eyes, kidneys, peripheral nerves, and so on;

• improve insulin-dependent tissue condition.

In type 2 treatment, stem cells can help:

• restore peripheral tissue sensitivity to insulin;

• reduce atherogenic hyperinsulinemia;

• decrease the production of glucose and pathologic lipids by liver cells;

• improve the condition of arterial walls, which is vital for the prevention of atherosclerosis and complications arising from it;

• reduce the dose of hypoglycemic medications.

Diabetes Treatment for Children

Fetal stem cell therapy is one of the most effective treatments for type 1 diabetes mellitus in children and the only one that can slow down or temporarily terminate autoimmune aggression against pancreatic beta cells.  If treatment is started within 6-8 weeks after onset, it is possible to prolong “honeymoon” period, sometimes for a long period of time.    

In children, fetal stem cell therapy results in:

• easier and better diabetes management

• prevention of blood sugar fluctuations (no hyper- and hypoglycaemia that might cause complications at later stages) 

• preservation of beta cell production by the pancreas (if treatment is started early after onset)

• prevention of serious diabetes-related complication

• immune boosting 

• better overall health and general development 

Stem cell therapy is most effective at the early stages of diabetes. The main criterion for positive effects with diabetes is long-term management of the disease and the inhibition or prevention of complications.